The Critical Role of Wall & Ceiling Systems in Drug Manufacturing
In pharmaceutical drug manufacturing, the physical environment is not merely a backdrop — it is an active component of the production process. Walls, ceilings, and partition systems must prevent contamination, withstand chemical exposure, support stringent cleaning protocols, and comply with international GMP regulations including EU GMP Annex 1, FDA 21 CFR Part 211, WHO TRS standards, and ISO 14644 cleanroom classifications.
Traditional construction materials such as gypsum board, standard drywall, and conventional sandwich panels often fall short of these demands. They are susceptible to moisture absorption, microbial growth, and surface degradation under repeated disinfection cycles. This is precisely where Magnesium Oxysulfate (MOS) panels have emerged as the industry-preferred solution.
🏭
Magnesium Oxysulfate panels deliver pharmaceutical-grade surface integrity, zero halogen emissions, and Class A fire resistance — the gold standard for cleanroom enclosures worldwide.
MOS panels are manufactured using a proprietary blend of magnesium oxide, magnesium sulfate, and reinforcing fibers, producing a dense, non-porous surface that resists moisture, bacteria, mold, and chemical agents. Their smooth, seamless finish is ideal for ISO Class 5–8 cleanrooms used in sterile injectable production, oral solid dosage manufacturing, API synthesis, and biopharmaceutical processing.
